1. Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults. (20th March 2011) Authors: Byakika-Kibwika, Pauline; Lamorde, Mohammed; Lwabi, Peter; Nyakoojo, Wilson B.; Okaba-Kayom, Violet; Mayanja-Kizza, Harriet; Boffito, Marta; Katabira, Elly; Back, David; Khoo, Saye; Merry, Concepta Other Names: Tamura Kazuo Academic Editor. Journal: Chemotherapy research and practice Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis. Issue 8 (20th May 2019) Authors: Back, David; Belperio, Pamela; Bondin, Mark; Negro, Francesco; Talal, Andrew H.; Park, Caroline; Zhang, ZhenZhen; Pinsky, Brett; Crown, Eric; Mensa, Federico J.; Marra, Fiona Journal: Journal of viral hepatitis Issue: Volume 26:Issue 8(2019) Page Start: 951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. (19th December 2018) Authors: Rajoli, Rajith K R; Curley, Paul; Chiong, Justin; Back, David; Flexner, Charles; Owen, Andrew; Siccardi, Marco Journal: Journal of infectious diseases Issue: Volume 219:Number 11(2019) Page Start: 1735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Frequency of Potential Drug–Drug Interactions in the Changing Field of HCV Therapy. (3rd February 2020) Authors: Schulte, Benjamin; Wübbolding, Maximilian; Marra, Fiona; Port, Kerstin; Manns, Michael P; Back, David; Cornberg, Markus; Stichtenoth, Dirk O; Höner zu Siederdissen, Christoph; Maasoumy, Benjamin Journal: Open forum infectious diseases Issue: Volume 7:Number 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The challenge of HIV treatment in an era of polypharmacy. Issue 2 (3rd February 2020) Authors: Back, David; Marzolini, Catia Journal: Journal of the International AIDS Society Issue: Volume 23:Issue 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational study. Issue 8 (August 2016) Authors: Olagunju, Adeniyi; Bolaji, Oluseye; Neary, Megan; Back, David; Khoo, Saye; Owen, Andrew Journal: Pharmaocogenetics and genomics Issue: Volume 26:Issue 8(2016:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Switching Safely: Pharmacokinetics, Efficacy and Safety of Switching Efavirenz to Maraviroc Twice Daily in Patients on Suppressive Antiretroviral Therapy. Issue 2 (February 2015) Authors: Waters, Laura; Jackson, Akil; Else, Laura; Rockwood, Neesha; Newell, Sally; Back, David; Nelson, Mark; Gazzard, Brian; Boffito, Marta Journal: Antiviral therapy Issue: Volume 20:Issue 2(2015) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection. (1st December 2016) Authors: Degasperi, Elisabetta; Caprioli, Flavio; El Sherif, Omar; Back, David; Colombo, Massimo; Aghemo, Alessio Journal: Expert review of gastroenterology & hepatology Issue: Volume 10:Number 12(2016) Page Start: 1373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Abacavir forms novel cross‐linking abacavir protein adducts in patients. (18th July 2014) Authors: Meng, Xiaoli; Lawrenson, Alexandre; Berry, Neil; Maggs, James; French, Neil; Back, David; Khoo, Saye; Naisbitt, Dean; Park, Kevin Journal: Clinical and translational allergy Issue: Volume 4:(2014)supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. (4th August 2020) Authors: Hodge, Catherine; Marra, Fiona; Marzolini, Catia; Boyle, Alison; Gibbons, Sara; Siccardi, Marco; Burger, David; Back, David; Khoo, Saye Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 12(2020) Page Start: 3417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗